Clinical Data's Cogenics Division Launches Services on Roche 454 GS FLX Sequencing System on Schedule
News Jun 07, 2007
Clinical Data Inc. has announced that its Cogenics division has successfully launched the 454 Genome Sequencer FLX system (the 454 FLX system) at its facility in Meylan, France, some eight weeks after the signing of the co-marketing agreement with Roche Diagnostics Inc., to offer next generation sequencing services.
The system enhances Cogenics' portfolio of services by providing whole genome sequencing, Expressed Sequence Tag sequencing, and identification of small RNAs, transcriptome analysis, and metagenomics on the new platform.
"Our team is enthusiastic about the level of customer interest in the 454 FLX system and pleased to be able to meet our customers' growing needs by providing complete solutions for low-cost and high-efficiency sequencing programs," stated Robert Bondaryk, Ph.D., Senior Vice President and General Manager of Cogenics.
"We have already attracted new customers for the first projects on the platform and we have a strong pipeline of current and new customer interest in 454 FLX sequencing as a companion to traditional automated Sanger sequencing,” Bondaryk added.
"I am truly excited about the speed and professionalism with which our team installed the 454 technology. This represents another example of Cogenics' strong technical abilities and commitment to leveraging proven advances in technology and quality for its clients," stated Drew Fromkin, Clinical Data's President and CEO. "We feel that the platform's ability to deliver value to our clients will translate into rapid, healthy returns for Cogenics.”
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Defects in Cell’s ‘Waste Disposal System’ Linked to Parkinson’sNews
An international study has shed new light on the genetic factors associated with Parkinson’s disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of this common neurodegenerative disorder.READ MORE
Mouse Model Demonstrates Potential of New Autism DrugNews
Scientists have performed a successful test of a possible new drug in a mouse model of an autism disorder. The candidate drug, largely corrected electrical, behavioral and brain abnormalities in the mice.READ MORE